Cite
HARVARD Citation
Cohen, J. et al. (2019). Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study. Multiple sclerosis. pp. 1255-1262. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cohen, J. et al. (2019). Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study. Multiple sclerosis. pp. 1255-1262. [Online].